Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohortHilary W Heuer, P Wang, K Rascovsky, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Utility of the global CDR<sup>®</sup> plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS ConsortiumToji Miyagawa, Danielle Brushaber, Jeremy Syrjanen, et al.
Nature Medicine|June 22, 2021
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseStephen Salloway, Martin Farlow, Eric McDade, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 25, 2019
Nonlinear Z-score modeling for improved detection of cognitive abnormalityJohn Kornak, Julie Fields, Walter Kremers, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 25, 2025
Sex differences in clinical phenotypes of behavioral variant frontotemporal dementiaXulin Liu, Sterre C M de Boer, Kasey Cortez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 6, 2019
Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degenerationAdam M Staffaroni, Yann Cobigo, Sheng-Yang M Goh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 1, 2019
Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degenerationNicholas T Olney, Elise Ong, Sheng-Yang M Goh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpointAdam M Staffaroni, Lynn Bajorek, Kaitlin B Casaletto, et al.
Pageof 20